View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Valens Research
  • Valens Research

TDG - Valens Credit Report - 2024 04 26

Credit markets are overstating credit risk, with a cash bond YTW of 6.901% relative to an Intrinsic YTW of 6.001% and an Intrinsic CDS of 134bps. Furthermore, Moody's is materially overstating TDG's fundamental credit risk with its highly speculative B1 credit rating five notches below Valens' IG4 (Baa2) credit rating. Incentives Dictate Behavior™ analysis highlights mostly negative signals for creditors. That said, most anagement members have low change-in-control compensation relative to thei...

Hillenbrand Inc: 4 directors

Four Directors at Hillenbrand Inc bought/maiden bought 6,237 shares at between 42.105USD and 42.690USD. The significance rating of the trade was 66/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's dir...

 PRESS RELEASE

Ocular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule...

Ocular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) BEDFORD, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL) (“Ocular”), a biopharmaceutical company committed to enhancing people’s vision and quality of life through the development and commercialization of innovative therapies for wet age-related macular degeneration (wet AMD), diabetic retinopathy, and other diseases and conditions of the eye, today announced that it has agreed to grant inducement awards to (i) its newly appointed Vice President, Head of Programming & Data Oper...

 PRESS RELEASE

Beyond, Inc. Reports First Quarter 2024 Financial Results

Beyond, Inc. Reports First Quarter 2024 Financial Results – Reported Revenue Growth on a Year-over-Year Basis – – Delivered 2.2 Million Orders, Representing a 27% YoY Increase in Transaction Volume – – Acquired Zulily, Doubling Down on Off-Priced Home and Lifestyle Business – – Soft Launched Iconic Overstock Site 6 Months Ahead of Schedule; Early Growth is Promising – MIDVALE, Utah, May 06, 2024 (GLOBE NEWSWIRE) -- Beyond, Inc. (NYSE:BYON), parent company of Overstock, Bed Bath & Beyond, Zulily, and other online retail brands designed to unlock your home’s potential, t...

 PRESS RELEASE

IFF Chief Financial and Business Transformation Officer Glenn Richter ...

NEW YORK--(BUSINESS WIRE)-- IFF (NYSE: IFF) today announced that Glenn Richter, IFF’s Chief Financial and Business Transformation Officer, plans to retire Dec. 31, 2024 after a three-year tenure with the company. A succession process has been initiated to evaluate internal and external candidates to succeed Richter as CFO. “During his time at IFF, Glenn has driven multiple actions to improve our balance sheet and position the company for financial success,” said Erik Fyrwald, IFF CEO. “We have benefited from his experience and commitment to transformation. Notably, the work he has led on por...

 PRESS RELEASE

IFF Reports First Quarter 2024 Results

NEW YORK--(BUSINESS WIRE)-- IFF (NYSE: IFF) reported financial results for the first quarter ended March 31, 2024. First Quarter 2024 Consolidated Summary: Reported (GAAP)   Adjusted (Non-GAAP)1 Sales   Income Before Taxes   EPS   Operating EBITDA   Operating EBITDA Margin   EPS ex Amortization $2.9 B   $115 M   $0.23   $578 M   19.9%   $1.13 Management Commentary "We have started the year well, with good results across the majority ...

Westlake Corp: 1 director

A director at Westlake Corp sold 4,950 shares at 152.190USD and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly s...

 PRESS RELEASE

Ocular Therapeutix™ to Present at Two Upcoming Investor Conferences

Ocular Therapeutix™ to Present at Two Upcoming Investor Conferences BEDFORD, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL, “Ocular”, the “Company”), a biopharmaceutical company committed to enhancing people’s vision and quality of life through the development and commercialization of innovative therapies for wet age-related macular degeneration (wet AMD), diabetic retinopathy, and other diseases and conditions of the eye, today announced that it will participate at two investor conferences in May: Citizens JMP Life Sciences Conference Fireside Chat Date:...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: May 4, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

Ocular Therapeutix™ To Present at Two Ophthalmology Meetings, May 4-9,...

Ocular Therapeutix™ To Present at Two Ophthalmology Meetings, May 4-9, 2024 2024 OIS Retina and ARVO meetings are being held in Seattle, Washington BEDFORD, Mass., May 03, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL, “Ocular”, the “Company”), a biopharmaceutical company committed to enhancing people’s vision and quality of life through the development and commercialization of innovative therapies for wet age-related macular degeneration (wet AMD), diabetic retinopathy, and other diseases and conditions of the eye, announced multiple presentations at the Ophthalmology...

Stephane Foucaud
  • Stephane Foucaud

AUCTUS ON FRIDAY - 03/05/2024

AUCTUS PUBLICATIONS ________________________________________ ADX Energy (ADX AU)C; target price of A$0.75 per share: Raising new equity to fund a high impact activity programme – ADX has raised A$13.5 mm of new equity priced at A$0.105 per share. One free-attaching option will be issued for evert two placement shares with an exercise price of A$0.15 per share and an expiry date of 08/05/2026. The proceeds from the raise will fund (1) the production testing of the 450 m gas column encountered at ...

 PRESS RELEASE

Cardlytics Announces Inducement Grants Under Nasdaq Listing Rule 5635(...

Cardlytics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) ATLANTA, May 02, 2024 (GLOBE NEWSWIRE) -- Cardlytics, Inc. (NASDAQ: CDLX), an advertising platform in banks’ digital channels, today announced that, on May 1, 2024, the Compensation Committee of Cardlytics’ Board of Directors granted an aggregate of 38,500 restricted stock units of Cardlytics to five newly hired employees. The restricted stock units were granted as material inducements to employment with Cardlytics in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted under the Cardlytics, Inc. 2022 I...

 PRESS RELEASE

Beyond, Inc. Announces Key Additions to Leadership Team

Beyond, Inc. Announces Key Additions to Leadership Team Industry experts join team to position enterprise for growth MIDVALE, Utah, May 02, 2024 (GLOBE NEWSWIRE) -- Beyond, Inc. (NYSE:BYON), owner of online retail giants Bed Bath & Beyond, Overstock and Zulily, today announced the addition and appointment of several key leaders to its team: Guncha Mehta, joining as Chief Digital and Information OfficerStacey Shively, joining as Chief Merchandising Officer, Bed Bath & BeyondAngela Minor, joining as Chief Marketing Officer, Bed Bath & BeyondDeb Bollom, appointed to Chief Merchandising Of...

 PRESS RELEASE

IFF Declares Dividend for Second Quarter 2024

NEW YORK--(BUSINESS WIRE)-- IFF (NYSE: IFF) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.40 per share of its common stock, payable on July 10, 2024 to shareholders of record as of June 21, 2024. Welcome to IFF At IFF (NYSE: IFF), an industry leader in food, beverage, scent, health and biosciences, science and creativity meet to create essential solutions for a better world – from global icons to unexpected innovations and experiences. With the beauty of art and the precision of science, we are an international collective of thinkers who partners ...

 PRESS RELEASE

Compass Diversified Reports First Quarter 2024 Financial Results

Compass Diversified Reports First Quarter 2024 Financial Results WESTPORT, Conn., May 01, 2024 (GLOBE NEWSWIRE) -- Compass Diversified (NYSE: CODI) (“CODI” or the “Company”), an owner of leading middle market businesses, announced today its consolidated operating results for the three months ended March 31, 2024. “We started 2024 on a strong note especially when you look at the performance of our Branded Consumer businesses, which only underscores the effectiveness of our well-defined, strategic pivot to own and manage companies at the forefront of innovation and disruptive growth,” said...

 PRESS RELEASE

Beyond Inc. Announces Expanded Investment in Salesforce Solutions to D...

Beyond Inc. Announces Expanded Investment in Salesforce Solutions to Drive Richer Customer Engagement and Experiences Beyond is tapping Data Cloud, Marketing Cloud, and MuleSoft to drive actionable insights from its customer data MIDVALE, Utah, May 01, 2024 (GLOBE NEWSWIRE) -- Today, Beyond, Inc. (NYSE:BYON), owner of ecommerce brands Bed Bath & Beyond, Overstock and Zulily, announced an expanded investment in Salesforce, the #1 AI CRM, to drive greater customer loyalty and deliver more personalized shopping experiences for their customers across all the company’s brands. Beyond will...

 PRESS RELEASE

Ocular Therapeutix™ to Host Investor Day in New York City on Thursday,...

Ocular Therapeutix™ to Host Investor Day in New York City on Thursday, June 13, 2024 First quarter 2024 financial results to be reported on Tuesday, May 7, 2024 Investor Day to replace first quarter 2024 earnings conference call; quarterly calls to resume regular cadence with second quarter 2024 financial results BEDFORD, Mass., May 01, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL, “Ocular”, the “Company”), a biopharmaceutical company committed to enhancing people’s vision and quality of life through the development and commercialization of innovative therapies for...

 PRESS RELEASE

Brookfield Reinsurance and AEL Announce Expected Closing Date for Broo...

WEST DES MOINES, Iowa--(BUSINESS WIRE)-- Brookfield Reinsurance (NYSE, TSX: BNRE) and American Equity Investment Life Holding Company (NYSE: AEL) (“AEL”) today announced that the previously announced acquisition of AEL by Brookfield Reinsurance is expected to close following the close of market on May 2, 2024. About AEL At American Equity Investment Life Holding Company, our policyholders work with over 40,000 independent agents and advisors affiliated with independent market organizations (IMOs), banks and broker-dealers through our wholly-owned operating subsidiaries. Advisors and agents...

 PRESS RELEASE

Compass Diversified Announces Sale of Crosman Air Gun Business

Compass Diversified Announces Sale of Crosman Air Gun Business WESTPORT, Conn., April 30, 2024 (GLOBE NEWSWIRE) -- Compass Diversified (NYSE: CODI) (“CODI” or the “Company”), an owner of leading middle market businesses, is announcing the simultaneous entry into a definitive agreement (the “Agreement”) and completion of its sale of Crosman Corporation (“Crosman”), the air gun division of its Velocity Outdoor, Inc. subsidiary, to Daisy Manufacturing Company (“Daisy”). Crosman is a leading designer, manufacturer and marketer of air guns, accessories and related consumables sold under the C...

Arcosa, Inc.: Update to credit analysis following ratings affirmation

Arcosa credit profile benefits from low leverage, strong and stable aggregates, while also considering it's relatively low margin and execution risk related to simplifying the business

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch